GLAXO PIONEERS NEW EUROPEAN DRUG PRICING MODEL

GlaxoSmithKline Plc has agreed new-style flexible pricing deals with two European governments, allowing it to raise the price of some drugs once additional clinical data on their value is available.

Scotsman (http://business.scotsman.com/latest.cfm?id=1381022006)